HEMATOLOGIC DISEASE AND DISORDERS
Clinical trials for HEMATOLOGIC DISEASE AND DISORDERS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC DISEASE AND DISORDERS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC DISEASE AND DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inside-Out attack: gene therapy builds cancer killers in the body
Disease control Recruiting nowThis early-stage trial tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or not responded to treatment. The therapy works by giving a single injection that instructs the body's own immune cells to become cancer-fighting cells (CAR-T cell…
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:59 UTC
-
New approach aims to tame immune storms in Half-Matched stem cell transplants
Disease control Recruiting nowThis study tests whether giving the immune-suppressing drug tacrolimus earlier than usual can lower the risk of cytokine release syndrome (a severe immune reaction) in people receiving a half-matched stem cell transplant for blood cancer. About 20 adults will take part, and resea…
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New study monitors hidden blood condition to predict future disease
Knowledge-focused Recruiting nowThis study follows 100 people aged 55 and older who have clonal hematopoiesis (CH) or possible CH, a condition where blood cells carry certain genetic changes. Researchers will monitor participants' health, check for risks of heart disease and blood cancers, and provide personali…
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Knowledge-focused
Last updated May 26, 2026 10:06 UTC